Our results showed that, compared with those in non-CE controls, the expression levels of sphingosine-1-phosphate lyase 1 (SGPL1), SPHK1, and SGPP2 were all significantly decreased in the endometrial tissues of CE patients (Fig. 4A). The gene discussed is SPHK1; the disease is cholesteryl ester measurement.